Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.76 |
| ▸ | HPGD | P15428 | 2/20 | 0.76 |
| ▸ | TSHR | P16473 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.68 |
| ▸ | CASP1 | P29466 | 1/20 | 0.68 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 1/20 | 0.52 |
| ▸ | TDO2 | P48775 | 1/20 | 0.52 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.50 |
| ▸ | TNKS | O95271 | 1/20 | 0.48 |
| ▸ | GUSB | P08236 | 1/20 | 0.48 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.48 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8621648 | 0.92 | KDM4E (0.89) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| SCHEMBL17367227 | 0.87 | KDM4E (0.93) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| SCHEMBL4142958 | 0.86 | KDM4E (1.00) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| Lithium SCHEMBL30669498 | 0.85 | KDM4E (0.96) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| SCHEMBL6329236 | 0.84 | KDM4E (0.76) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| SCHEMBL28022669 | 0.82 | HSD17B10 (0.78) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| SCHEMBL6871615 | 0.81 | KDM4E (1.00) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| SCHEMBL29130443 | 0.81 | KDM4E (0.71) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| SCHEMBL7702065 | 0.80 | KDM4E (0.65) | KDM4EHSD17B10ALDH1A1HPGDTSHR | |
| Urea SCHEMBL15312604 | 0.79 | KDM4E (0.84) | KDM4EHSD17B10ALDH1A1HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10032991-B2 | Compound, organic electroluminescence element material, ink composition, organic electroluminescence element, electronic device, and method for producing compound | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10032991-B2 | Compound, organic electroluminescence element material, ink composition, organic electroluminescence element, electronic device, and method for producing compound | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-20160197288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160197288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20090062317-A1 | MEDICINAL USE OF RECEPTOR LIGANDS | 7TM PHARMA A/S (DK) | 2009-03-05 | — | — | US | disclosed |
| EP-1778670-A2 | MEDICINAL USE OF RECEPTOR LIGANDS | 7TM Pharma A/S (DK) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006010446-A2 | MEDICINAL USE OF RECEPTOR LIGANDS | 7TM PHARMA A/S (DK) | 2006-02-02 | — | — | WO | disclosed |
| US-5849861-A | Polyquinazolines and methods for their preparation | HITACHI CHEMICAL CO., LTD. (JP) | 1998-12-15 | — | — | US | disclosed |
| US-5686560-A | TREATING A MONOMER WITH A BASE IN A DIPOLAR SOLVENT | HITACHI CHEMICAL CO., LTD. (JP) | 1997-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160197288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING COMPOUND | LEF1, L1CAM, OLA1 | KDM4E 2220/4885HSD17B10 3231/4885ALDH1A1 66/4885 |
| US-20090062317-A1 | MEDICINAL USE OF RECEPTOR LIGANDS | MCHR1, MCHR2, MC1R | KDM4E 3078/4885HSD17B10 546/4885ALDH1A1 1058/4885 |
| US-10032991-B2 | Compound, organic electroluminescence element material, ink composition, organic electroluminescence element, electronic device, and method for producing compound | LEF1, L1CAM, OLA1 | KDM4E 2220/4885HSD17B10 3231/4885ALDH1A1 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.